{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-cancer-care-pain/management/acute-severe-pain/","result":{"pageContext":{"chapter":{"id":"377406aa-05e6-5559-9f6e-4404453e407c","slug":"acute-severe-pain","fullItemName":"Scenario: Acute severe pain","depth":2,"htmlHeader":"<!-- begin field 52551179-92bd-45fa-bd64-cd233bd6aa9d --><h2>Scenario: Acute severe pain</h2><!-- end field 52551179-92bd-45fa-bd64-cd233bd6aa9d -->","summary":"Covers the immediate management of acute, severe pain prior to assessment.","htmlStringContent":"<!-- begin item 98700187-5080-45fa-8ce2-dfb5e2cec91b --><!-- begin field b2ffa4ef-0f39-40a0-b0a1-acbd0086a0ce --><p>From age 16 years onwards.</p><!-- end field b2ffa4ef-0f39-40a0-b0a1-acbd0086a0ce --><!-- end item 98700187-5080-45fa-8ce2-dfb5e2cec91b -->","topic":{"id":"bc60f031-53af-530c-93e6-59feeef85bcb","topicId":"305b6c55-5a1b-4817-87a1-c88490ac688b","topicName":"Palliative cancer care - pain","slug":"palliative-cancer-care-pain","lastRevised":"Last revised in September 2020","chapters":[{"id":"edd133a3-7ad6-5893-82e6-230eb9313dd3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6c915659-224b-530e-9fb3-c0b95720d118","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"362828da-ca6f-5900-8441-afd9ea44af5b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"cd526925-546a-5aac-93eb-485967fb5fd7","slug":"changes","fullItemName":"Changes"},{"id":"42928747-95fa-57d3-ae9e-7e3a6cf476a5","slug":"update","fullItemName":"Update"}]},{"id":"30edbf0f-7363-5f35-8126-77659a917fa3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"21b41383-eea4-5b71-8b34-687f05a65a5d","slug":"goals","fullItemName":"Goals"},{"id":"6ae0a52d-6ca2-5d97-8aa0-2beccf699f7e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d2aefa77-c551-539d-be41-67260cbe43ac","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7bc8c749-a90c-532b-854e-5ee96116de81","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"cf494151-3dcb-5990-851a-dd1cd70fab0c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"9b0ea843-6c18-543c-b4f3-cbf22a737e5a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1078edd0-49b8-514b-aa1f-462d95bcb62c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"203a281c-b6df-5d53-a704-aae8df1662a6","slug":"definition","fullItemName":"Definition"},{"id":"7842468e-5e33-52dc-ade6-5149de1e1436","slug":"origins-of-pain","fullItemName":"Origins of pain"},{"id":"cc8e90f5-0cd6-54d0-9bec-75e0729d34b2","slug":"prevalence","fullItemName":"Prevalence"}]},{"id":"288e99e9-418d-5e10-8b3b-94d111f68f63","fullItemName":"Management","slug":"management","subChapters":[{"id":"377406aa-05e6-5559-9f6e-4404453e407c","slug":"acute-severe-pain","fullItemName":"Scenario: Acute severe pain"},{"id":"3bc406e3-6db0-5386-a1a1-94f551e50a8d","slug":"assessment-of-pain","fullItemName":"Scenario: Assessment of pain"},{"id":"bfa2c711-266a-5133-a082-0655b9243bb5","slug":"managing-pain-non-emergency","fullItemName":"Scenario: Managing pain - non-emergency"},{"id":"fe447a1c-0019-5592-92ea-3d018c455b3b","slug":"managing-neuropathic-pain","fullItemName":"Scenario: Managing neuropathic pain"},{"id":"ffae5598-ad34-57a7-bb50-018dcb5f63c8","slug":"managing-intracranial-pressure-pain","fullItemName":"Scenario: Managing intracranial pressure pain"},{"id":"43317aee-6f8f-5d85-afed-94ec4c221bc5","slug":"managing-colic","fullItemName":"Scenario: Managing colic"},{"id":"4f3f67af-bf6a-5f02-84e4-c48ecc292167","slug":"managing-bone-pain","fullItemName":"Scenario: Managing bone pain"},{"id":"5c6257ce-9559-5775-a6e4-13eceaacff04","slug":"managing-muscle-spasm-pain","fullItemName":"Scenario: Managing muscle spasm pain"},{"id":"dba15959-96fa-5968-81ac-b3eb2b17604e","slug":"spinal-cord-compression","fullItemName":"Scenario: Spinal cord compression"},{"id":"d4083f8f-2904-55e8-9cb5-b20f6fcf10d2","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"}]},{"id":"32fe1b7d-4328-56b2-9102-e26bc06c421d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"6452b6ef-626b-552e-bf5c-0c21daf91352","slug":"nsaids","fullItemName":"NSAIDs"},{"id":"2ca1fa6a-d245-53df-a4e5-79f63db752f1","slug":"codeine-dihydrocodeine-tramadol","fullItemName":"Codeine, dihydrocodeine and tramadol"},{"id":"9d55dc66-3dff-524e-9ed1-7919aeca221b","slug":"strong-opioids","fullItemName":"Strong opioids"},{"id":"47ef042e-05dc-576a-81b5-e9d12888c2e8","slug":"tricyclic-antidepressants","fullItemName":"Tricyclic antidepressants"},{"id":"e39f9314-9fbb-5007-a7cf-c5ac3776546b","slug":"pregabalin","fullItemName":"Pregabalin"},{"id":"25156d8c-bb99-5e69-bf39-538e1a2c0265","slug":"gabapentin","fullItemName":"Gabapentin"},{"id":"58fbb7ca-b553-553e-8038-39021cfa2440","slug":"dexamethasone","fullItemName":"Dexamethasone"},{"id":"2e657be1-22f8-5617-85b0-b0d657de037e","slug":"diazepam","fullItemName":"Diazepam"},{"id":"d07c8c77-b362-533f-8d19-5397cdb2c2a6","slug":"baclofen","fullItemName":"Baclofen"},{"id":"e56de34b-8fb3-5a88-88fd-52f21822c95e","slug":"hyoscine-butylbromide","fullItemName":"Hyoscine butylbromide"}]},{"id":"ba95315f-c704-52b3-8e69-b66132db1afc","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[{"id":"36e5ad13-c74b-5b5b-a91a-dc99c76fe16c","slug":"drugs-to-treat-neuropathic-pain","fullItemName":"Drugs to treat neuropathic pain"}]},{"id":"e0efe998-f4e8-511b-9d28-24afd40c557e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"de1ea0e8-6fc9-51d7-85ca-027ba77b3439","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"db05b928-3724-5155-8572-4a5741697b59","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"ad310ea3-10a0-5123-a3cb-4623f775c2a6","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ae075009-b5ea-57cb-9dab-2d35fa7facb1","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"103ff2fc-2fa3-5785-a596-c4145bf1037f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"445d177d-22b8-5eef-aeaf-b7b0ae34c259","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"288e99e9-418d-5e10-8b3b-94d111f68f63","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"b308b58c-dd39-5cd3-83b8-657e33925dd3","slug":"management-of-acute-severe-pain","fullItemName":"Management of acute severe pain","depth":3,"htmlHeader":"<!-- begin field 09496fdb-aece-476e-ae43-20090329155e --><h3>How should I manage acute severe pain?</h3><!-- end field 09496fdb-aece-476e-ae43-20090329155e -->","summary":null,"htmlStringContent":"<!-- begin item 17c3b8b4-7aac-4912-9c92-145cce072a7a --><!-- begin field 66f6a9a3-c6cc-46a6-bfbc-5ce85f82decd --><ul><li><strong>Immediately relieve pain using a subcutaneous or slow intravenous dose of a strong opioid.</strong></li><li>The dose depends on the person's comorbidities and their existing analgesia:<ul><li>If the person is opioid naive, consider a subcutaneous or slow intravenous dose of 5 mg of morphine (2.5 mg if the person is elderly or frail).</li><li>If the person is already taking a regular opioid, calculate the 4-hourly dose by taking the total dose given over the previous 24 hours (including doses required for breakthrough pain but excluding those for incident pain) and dividing it by six, and then give the equivalent subcutaneous dose of morphine:<ul><li>The subcutaneous dose of morphine is approximately half of the 4-hourly oral morphine dose.</li><li>For more detailed information on converting oral morphine to a subcutaneous dose, see the conversion table in <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/prescribing-information/strong-opioids/#switching-from-morphine-to-another-strong-opioid\">Switching from morphine to another strong opioid</a>.</li></ul></li></ul></li><li><strong>Following this, seek immediate specialist palliative care advice regarding further management and try to determine the cause of the pain.</strong></li><li><strong>Always take into account the person's circumstances and wishes:</strong><ul><li>If the person wishes to stay at home and is near the end of life, then control of symptoms should be attempted in this setting; if this is not possible, transfer to a hospice or hospital may be needed.</li></ul></li></ul><!-- end field 66f6a9a3-c6cc-46a6-bfbc-5ce85f82decd --><!-- end item 17c3b8b4-7aac-4912-9c92-145cce072a7a -->","subChapters":[{"id":"e8d1968f-02b3-571c-9877-0ec4af36916a","slug":"basis-for-recommendation-686","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field be13885d-dd87-463c-ae43-2af3f04bfec4 --><h4>Basis for recommendation</h4><!-- end field be13885d-dd87-463c-ae43-2af3f04bfec4 -->","summary":null,"htmlStringContent":"<!-- begin item 686d6db4-fdc5-4741-980d-1b6bd34e23d7 --><!-- begin field 1d50b6e0-ae5e-4e1a-8a50-77b0d61f2241 --><p>There is no expert consensus on how to manage a person with acute, severe pain. Opinion varies widely with respect to the preferred drug, route of administration, and doses used. CKS has offered a simple pragmatic approach for immediate management based on opinion from expert reviewers.</p><ul><li>These recommendations are consistent with published expert opinion from a text book; <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/references/\">Regnard, 2010</a>] and guidelines published by NHS Lothian [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/references/\">NHS Lothian, 2014a</a>].</li></ul><h5>Diamorphine</h5><ul><li>Recently published guidelines from the National Institute for Clinical Excellence (NICE) found no published evidence that compared the effectiveness of subcutaneous morphine with subcutaneous diamorphine [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/references/\">National Collaborating Centre for Cancer, 2016</a>]. The NICE guideline development group concluded that the subcutaneous opioid with the lowest acquisition cost should be prescribed. At the time of writing, diamorphine injection is approximately three times more expensive than morphine injection. CKS have therefore recommended the use of morphine injection for people with acute severe pain.</li><li>In addition, following on from a protracted supply problem with diamorphine which has been resolved, many palliative care centres now use morphine in preference to diamorphine [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/references/\">Twycross et al, 2009</a>].</li></ul><!-- end field 1d50b6e0-ae5e-4e1a-8a50-77b0d61f2241 --><!-- end item 686d6db4-fdc5-4741-980d-1b6bd34e23d7 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}